ישראל -
עברית -
Ministry of Health
devices to aid people with disabilities
abramov-gal ltd. - אחר - מתקני עזר + נלווים למוגבלים בתפקוד בשירותים ובמטבחהמסווגים בקלאס i
ישראל -
עברית -
Ministry of Health
drugcheck
איילקס מדיקל בע"מ - מומחה - ערכות לניטור סמים בשתן וברוק,ערכות לגילוי הריון בשתן ובסרום
ישראל -
עברית -
Ministry of Health
סורמונטיל 25 מ"ג
sanofi - aventis israel ltd - trimipramine as maleate 25 mg - tablets - trimipramine - antidepressant.
ישראל -
עברית -
Ministry of Health
הרספטין 440 מג i.v
roche pharmaceuticals (israel) ltd - trastuzumab - תמיסה לאינפוזיה - trastuzumab 440 mg/ml - trastuzumab - trastuzumab - herceptin is indicated for the treatment of patients with metastatic breast cancer who have tumours that overexpress her2: 1. as a single agent for the treatment of those patients who have received one or more chemotherapy regiments for their metastatic disease. 2. in combination with paclitaxel or docetaxel for the treatment of those patients who have not received chemotherapy for their metastatic disease. 3. herceptin in combination with an aromatase inhibitor for the treatment of postmenopausal patients with hormone-receptor positive metastatic breast cancer. early breast cancer (ebc) :herceptin is indicated to treat patients with her2-positive early breast cancer following surgery and chemotherapy (neoadjuvant or adjuvant) either alone or in combination with chemotherapy excluding anthracyclines. herceptin should only be used in patients whose tumors have either her2 overexpression or her2 gene amplification as determined by an accurate and validated assay.her2 metastatic gastric cancer (mgc)herceptin in